Showing results (111-120 of 377) with videos related to

Sort By:
Pageof 38
British Journal of Cancer|August 24, 2022
How do women who are informed that they are at increased risk of breast cancer appraise their risk? A systematic review of qualitative researchVictoria G Woof, Anthony Howell, Lorna McWilliams, et al.
Cell Cycle (Georgetown, Tex.)|October 17, 2012
Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistanceAhmed F Salem, Diana Whitaker-Menezes, Anthony Howell, et al.
Neurogenetics|March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosisMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1D Gareth R Evans, Hector Salvador, Vivian Y Chang, et al.
European Journal of Human Genetics : EJHG|June 23, 2011
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989D Gareth R Evans, Catherine O'Hara, Anna Wilding, et al.
International Journal of Cancer|September 8, 2011
Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefitAndrew Maurice, D Gareth Evans, Jenny Affen, et al.
The Lancet. Oncology|December 18, 2007
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial, John F Forbes, Jack Cuzick, et al.
JAMA Network Open|April 19, 2024
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic VariantsZhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, et al.
Developmental Biology|December 25, 2004
A putative human breast stem cell population is enriched for steroid receptor-positive cellsRobert B Clarke, Katherine Spence, Elizabeth Anderson, et al.
BMC Cancer|June 3, 2008
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the familyD Gareth Evans, Andrew Shenton, Emma Woodward, et al.
Pageof 38